Big Data in Life Sciences

As the useful applications of big data in the pharmaceutical and healthcare sector become increasingly apparent, 73% of organizations in the industry are set to begin or increase investment in big data within the next five years, according to business intelligence provider GBI Research.

The report shows that those companies that already use big data and those that do not are in agreement over the impact big data can have on the industry, suggesting that the trend is not heavily biased by the organization’s current status with regard to the technology. The main difference between the two is that those that currently use big data believe more strongly that it can have a big impact on sales, marketing, and commercial activities

Click here for the full story in the March 2017 digital edition